Skip to main content
TipRanks
Go Ultimate75% OFF

Rapid Dose Therapeutics Corp (RDTCF) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

RDTCF Analyst Ratings

There are no analyst ratings in the last 3 months.

RDTCF Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for RDTCF
Price TargetArticle
TipRanks - PerPlexity$0.07→$0.06sell-15.49%DownsideReiterated11/04/26
TipRanks - Google$0.07→$0.06sell-15.49%DownsideReiterated11/04/26
TipRanks - Anthropic$0.07→$0.06sell-23.44%DownsideReiterated11/04/26
TipRanks - OpenAI$0.08→$0.06hold-13.50%DownsideReiterated11/04/26
TipRanks - DeepSeek$0.08→$0.06sell-15.49%DownsideDowngraded11/04/26
TipRanks - xAI$0.08→$0.06sell-15.49%DownsideReiterated11/04/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
MIRMMirum Pharmaceuticals
CSTLCastle Biosciences
PVLAPalvella Therapeutics
RZLTRezolute

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Rapid Dose Therapeutics Corp

3 Months
Google Health Care CA
Google Health Care CATipRanks - Google
Success Rate2/3 ratings generated profit
67%
Average Return
+7.67%

Copying Google Health Care CA's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +7.67% per trade.

1 Year
Google Health Care CA
Google Health Care CATipRanks - Google
Success Rate2/3 ratings generated profit
67%
Average Return
+7.67%

Copying Google Health Care CA's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +7.67% per trade.

2 Years
Google Health Care CA
Google Health Care CATipRanks - Google
Success Rate2/3 ratings generated profit
67%
Average Return
+7.67%

Copying Google Health Care CA's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +7.67% per trade.

RDTCF Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for RDTCF
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, RDTCF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RDTCF average Analyst price target in the past 3 months is ―.

RDTCF Financial Forecast

$-2$-1.5$-1$-0.5$0Q3 2026Q2 2027Q3 2027
Consensus$-0.00

RDTCF Earnings Forecast

Next quarter’s earnings estimate for RDTCF is $0.00 with a range of ― to ―. The previous quarter’s EPS was $0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$155,043$236,715.8$318,388.5$400,061.3$481,734Q3 2026Q2 2027Q3 2027
Consensus$155K

RDTCF Sales Forecast

Next quarter’s sales forecast for RDTCF is $155.04K with a range of ― to ―. The previous quarter’s sales results were $155.04K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

RDTCF Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Rapid Dose Therapeutics Corp?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of RDTCF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.